Sandeep K. Bansal
Expertise in
50
conditions

Dr. Sandeep K. Bansal

Pulmonary Medicine | Intensive Care Medicine
Dubois Regional Medical Center
100 Hospital Ave, 
Du Bois, PA 
Expertise in
50
conditions
Dubois Regional Medical Center
100 Hospital Ave, 
Du Bois, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sandeep Bansal is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Du Bois, Pennsylvania. Dr. Bansal is highly rated in 50 conditions, according to our data. His top areas of expertise are Lung Nodules, Asthma, Asthma in Children, Advanced Bronchoscopy, and Gastrostomy.

His clinical research consists of co-authoring 139 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Internal Medicine in PA
Hospital Affiliations
Penn Highlands Elk
Penn Highlands Dubois
Penn Highlands Brookville
Penn Highlands Huntingdon
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

DUBOIS REGIONAL MEDICAL CENTER
100 Hospital Ave, Du Bois, PA 15801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
Evaluating MRI Scanning in Patients With Fractured or Abandoned Endocardial Leads
Evaluating MRI Scanning in Patients With Fractured or Abandoned Endocardial Leads
Enrollment Status: Terminated
Publish Date: September 16, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Device
Study Phase: Not Applicable
Zephyr Valve Registry
Zephyr Valve Registry
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Device
Needle-Based Confocal Laser Endomicroscopy to Aid in Lung Nodule Localization by Robotic-Assisted Navigational Bronchoscopy
Needle-Based Confocal Laser Endomicroscopy to Aid in Lung Nodule Localization by Robotic-Assisted Navigational Bronchoscopy
Enrollment Status: Completed
Publish Date: April 25, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Device
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Phase IV, 12 Week, Randomised, Double-blind, Double-dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI), With Tiotropium Monotherapy Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
A Phase IV, 12 Week, Randomised, Double-blind, Double-dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI), With Tiotropium Monotherapy Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: July 15, 2021
Intervention Type: Drug, Device
Study Phase: Phase 4
Establishment of a Registry for Patients Treated With Photodynamic Therapy (PDT)
Establishment of a Registry for Patients Treated With Photodynamic Therapy (PDT)
Enrollment Status: Terminated
Publish Date: February 24, 2020
Intervention Type: Other
A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection
A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection
Enrollment Status: Completed
Publish Date: January 13, 2020
Intervention Type: Device, Drug
Study Phase: Phase 1
View 12 Less Clinical Trials

139 Total Publications

Tachycardia alert from an implantable loop recorder after brain magnetic resonance imaging-The importance of patient history.
Tachycardia alert from an implantable loop recorder after brain magnetic resonance imaging-The importance of patient history.
Journal: HeartRhythm case reports
Published: December 03, 2025
Similar Doctors
Expertise in
29
conditions
Dr. Rajesh S. Rao
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine
Expertise in
29
conditions
Dr. Rajesh S. Rao
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine

Dubois Regional Medical Center

100 Hospital Ave, 
Du Bois, PA 
 (0.1 miles away)
814-375-3770
Languages Spoken:
English
See accepted insurances

Rajesh Rao is a Pulmonary Medicine specialist and a Sleep Medicine provider in Du Bois, Pennsylvania. Dr. Rao is highly rated in 29 conditions, according to our data. His top areas of expertise are Asthma, Asthma in Children, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, and Gastrostomy.

Expertise in
13
conditions
Dr. Angelo Illuzzi
Pulmonary Medicine | Sleep Medicine
Expertise in
13
conditions
Dr. Angelo Illuzzi
Pulmonary Medicine | Sleep Medicine

Dubois Regional Medical Center

621 S Main St, Penn Highlands Pulmonology, 
Dubois, PA 
 (0.1 miles away)
814-375-5305
Languages Spoken:
English
See accepted insurances

Angelo Illuzzi is a Pulmonary Medicine specialist and a Sleep Medicine provider in Dubois, Pennsylvania. Dr. Illuzzi is highly rated in 13 conditions, according to our data. His top areas of expertise are Asthma, Asthma in Children, Asbestosis, and Lung Metastases.

Expertise in
8
conditions
Dr. Timothy P. Pendleton
Pulmonary Medicine | Intensive Care Medicine
Expertise in
8
conditions
Dr. Timothy P. Pendleton
Pulmonary Medicine | Intensive Care Medicine
111 Summit Street, 
Brookville, PA 
 (16.3 miles away)
814-849-8329
Languages Spoken:
English
See accepted insurances

Timothy Pendleton is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Brookville, Pennsylvania. Dr. Pendleton is highly rated in 8 conditions, according to our data. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, and Pneumonia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bansal's expertise for a condition
ConditionClose
    View All 19 Distinguished Conditions
    View All 31 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile